Original investigationPharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis
References (24)
- et al.
Detection and quantitation of gadolinium chelates in human serum and urine by high-performance liquid chromatography and post-column derivatization of gadolinium with Arsenazo III
J Pharmaceut Biomed Analg
(1995) - et al.
Gd-DOTA: evaluation of its renal tolerance in patients with chronic renal failure
Magn Reson Imaging
(1992) - et al.
Elimination of Gd-DTPA by means of hemodialysis
Eur J Radiol
(1990) - et al.
A phase I clinical trial with gadodiamide, a nonionic magnetic resonance imaging enhancement agent
Invest Radiol
(1991) - et al.
Pharmacokinetics of gadodiamide in patients with moderately impaired renal function
Acad Radiol
(1994) - et al.
Pharmacokinetics of Gd-DTPA in patients with chronicrenal failure
Invest Radiol
(1991) - et al.
Pharmacokinetics and tolerance of Gd-DOTA (DOTAREM) in healthy volunteers and in patients with chronic renal failure
Eur Radiol
(1992) - et al.
Hemodialysis for elimination of nonionic contrast medium iohexol after angiography in patients with impaired renal function
Nephron
(1995) - et al.
Pharmakokinetik von gadolinium-DTPA bei dialysepflichtiger chronischer niereninsuffizienz
Roe Foe
(1992) - et al.
The dialysability of Gd-DTPA
A simple method for the determination of glomerular filtration rate
Scand J Clin Lab Invest
Cited by (293)
European fluxes of medical gadolinium to the ocean: A model based on healthcare databases
2023, Environment InternationalOne-step Method to Fabricate Poly(ethylene terephthalate)/Gd(OH)<inf>3</inf> Magnetic Nanofibers tTowards MRI-active Materials with High T<inf>1</inf> Relaxivity and Long-term Visibility
2022, GiantCitation Excerpt :However, due to their high water-solubility, CAs were rapidly dissolved in the environment. The in vivo half-lives of Gd-DTPA (13.1 minutes [48]) and gadodiamide (1.3 hours [49]) were too short for them to provide long-term MRI visibility. Thus, a water-insoluble CA with high T1 relaxation acceleration efficiency (i.e., T1 relaxivity) is needed to endow electrospun fibers with long-term positive contrast.
Stability of MRI contrast agents in high-energy radiation of a 1.5T MR-Linac
2021, Radiotherapy and OncologySpeciation analysis of Gadolinium-based contrast agents using aqueous eluent-hydrophilic interaction liquid chromatography hyphenated with inductively coupled plasma-mass spectrometry
2021, TalantaCitation Excerpt :These agents can be divided into macrocyclic compounds (Gd-HP-DO3A, Gd-DOTA, and Gd-BT-DO3A) and linear compounds (Gd-DTPA, Gd-DTPA-BMA, and Gd-EOB-DO3A) (Fig. S1). Because of their high complex stability, they are considered to be safe for the human body [6]. However, administration of Gd-based contrast agents for patients with renal failure involves a risk for nephrogenic systemic fibrosis (NSF) [7–9].
Anthropogenic gadolinium in freshwater and drinking water systems
2020, Water Research